Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 14 Prostatic Neoplasms 9 Leukemia, Myeloid, Acute 9 Endometrial Neoplasms 8 Breast Neoplasms 7 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Lung Neoplasms 5 Colonic Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Multiple Myeloma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Mouth Neoplasms 3 Lymphoma, Follicular 3 Leukemia 3 Esophageal Neoplasms 3 Brain Neoplasms 3

Interventions

Carboplatin 26 Etoposide 22 Vincristine 18 Melphalan 14 Filgrastim 14 Topotecan 11 Granulocyte Colony-Stimulating Factor 10 Cyclophosphamide 9 Thiotepa 7 Cryotherapy 6 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Drug Therapy 4 Busulfan 4 Radiotherapy 3 Ifosfamide 3 Doxorubicin 3 Temozolomide 2 Platinum Compounds 2 Eye Enucleation 2 Cisplatin 2 Brachytherapy 2 trioctyl phosphine oxide 1 sargramostim 1 racotumomab 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 etoposide phosphate 1 cixutumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Retinoblastoma × Observation × Clear all

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡